Anxiety symptoms: An at-home device shown to reduce symptoms by 60 percent
ANXIETY symptoms: Shocking statistics in mental health in the UK reveal two thirds of Britons suffer with some form of mental health issues but receive no treatment. Could an at-home device help to cure anxiety and insomnia symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2022 Category: Consumer Health News Source Type: news

How to sleep: The 'sweet-smelling' drink 'for alleviating insomnia' - study
SLEEPING through the night is not something everyone is always able to do, and there is a lot of advice to be found around improving your quality of sleep, and adopting healthy sleep routines. (Source: Daily Express - Health)
Source: Daily Express - Health - January 21, 2022 Category: Consumer Health News Source Type: news

Prevalence of insomnia and insomnia symptoms following mild-traumatic brain injury: a systematic review and meta-analysis - Montgomery MC, Baylan S, Gardani M.
Sleep is commonly disrupted following mild traumatic brain injury (mTBI), however there is a lack of consensus in the existing literature regarding the prevalence of insomnia/insomnia symptoms after injury. The aim of this review was to conduct a systemati... (Source: SafetyLit)
Source: SafetyLit - January 18, 2022 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

PROFESSOR GUY LESCHZINER: How to banish your insomnia without pills
PROFESSOR GUY LESCHZINER: Over 15 years as a neurologist specialising in sleep, I've treated every disorder under the sun (or perhaps I should say moon). (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2022 Category: Consumer Health News Source Type: news

Why Jennifer Aniston is helping a pharmaceutical firm take on insomnia
Idorsia, a Swiss pharmaceutical company with U.S. operations on the Main Line, has recruited actress Jennifer Aniston to help the company educate people about insomnia. Commercials featuring Aniston talking about the sleeping disorder that afflicts an estimated 25 million Americans will start airing Monday, a week after Idorsia received marketing clearance from the Food and Drug Administration for its first product: the insomnia treatment Quviviq. The commercial starring the former "Friends" star… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 15, 2022 Category: American Health Authors: John George Source Type: news

How to beat the insomnia epidemic caused by Covid anxiety, PROFESSOR GUY LESCHZINER writes 
PROFESSOR GUY LESCHZINER: Whether as a symptom of long Covid or as a side-effect of living through heightened stress, the pandemic has had a terrible effect on the world of sleep. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2022 Category: Consumer Health News Source Type: news

Can talk therapy help you sleep better?
Addressing the reasons behind insomnia is an alternative to medication. (Source: PsycPORT.com)
Source: PsycPORT.com - January 13, 2022 Category: Psychiatry Source Type: news

Public Notification: Tawon Liar mengandung bahan obat tersembunyi
Badan Pengawas Obat dan Makanan (FDA) mengimbau konsumen untuk tidak membeli atau mengonsumsi produk yang dipromosikan dan dijual untuk meredakan nyeri, rematik, menghilangkan insomnia, meningkatkan sistem kekebalan tubuh, menambah energi, dan mengurangi kolesterol dengan merek Tawon Liar di berbaga (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 13, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Why Jennifer Aniston is helping a Main Line pharmaceutical firm take on insomnia
Idorsia, a Swiss pharmaceutical company with U.S. operations on the Main Line, has recruited actress Jennifer Aniston to help the company educate people about insomnia. Commercials featuring Aniston talking about the sleeping disorder that afflicts an estimated 25 million Americans will start airing Monday, a week after Idorsia received marketing clearance from the Food and Drug Administration for its first product: the insomnia treatment Quviviq. The commercial starring the former "Friends" star… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 13, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

Validating Insomnia Severity Index (ISI) in a Bangladeshi population: using classical test theory and Rasch analysis - Mamun MA, Alimoradi Z, Gozal D, Manzar MD, Brostr öm A, Lin CY, Huang RY, Pakpour AH.
The COVID-19 outbreak is associated with sleep problems and mental health issues among individuals. Therefore, there is a need to assess sleep efficiency during this tough period. Unfortunately, the commonly used instrument on insomnia severity-the Insomni... (Source: SafetyLit)
Source: SafetyLit - January 13, 2022 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Melatonin for Sleep: How the Aid Works
The “vampire hormone” can act like a dose of sunset, tricking your body into feeling like it’s time to sleep. (Source: NYT Health)
Source: NYT Health - January 11, 2022 Category: Consumer Health News Authors: Amelia Nierenberg Tags: Quarantine (Life and Culture) Sleep Content Type: Service Melatonin (Hormone) Dreams Insomnia Psychology and Psychologists Anxiety and Stress Sedatives Drugs (Pharmaceuticals) Jet Lag Source Type: news

Why fruit and veg could be nature's secret sleep remedy
Studies have found that around a third of people in the UK suffer from insomnia, meaning they struggle to fall or stay asleep, and around two million people rely on sleeping pills. (Source: the Mail online | Health)
Source: the Mail online | Health - January 11, 2022 Category: Consumer Health News Source Type: news

FDA Approves Quviviq (daridorexant) for the Treatment of Adults with Insomnia
Allschwil, Switzerland– January 10, 2022 Idorsia Ltd (SIX: IDIA) today announced that the US Food and Drug Administration (FDA) has approved Quviviq (daridorexant) 25 mg and 50 mg for the treatment of adult patients with insomnia,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 10, 2022 Category: Drugs & Pharmacology Source Type: news

A longitudinal study of insomnia, daytime sleepiness, and academic performance in Chinese adolescents - Zhang L, Yang Y, Luo Y, Liu ZZ, Jia CX, Liu X.
This study examined the cross-sectional and longitudinal associations between insomnia... (Source: SafetyLit)
Source: SafetyLit - January 10, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

FDA OKs New Adult Insomnia Med FDA OKs New Adult Insomnia Med
The approval was based on a phase 3 trial showing daridorexant was associated with improved sleep onset, sleep maintenance, and daytime functioning in adults with insomnia.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 10, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA approves insomnia drug developed by Swiss company with Main Line operations
The company established U.S. operations in Radnor during the Covid-19 pandemic. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 10, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

Ask These Key Questions About Atopic Dermatitis Sleep Problems Ask These Key Questions About Atopic Dermatitis Sleep Problems
Assessment tools to consider are the Epworth Sleepiness Scale, the Insomnia Severity Index, and the STOP-Bang questionnaire.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 9, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Public Notification: Tawon Liar contains hidden drug ingredient
FDA is advising consumers not to purchase or use Tawon Liar, a product promoted and sold for pain, rheumatism, insomnia, improving the immune system, increasing energy, and lowering cholesterol on various websites, including www.etsy.com, and possibly in some retail stor (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 7, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Why are CBD products so popular when there's not a jot of evidence they do anything for our health? 
CBD advocates claim it can do everything from treating insomnia, anxiety and joint pain to helping with serious conditions such as high blood pressure and even the eye disease glaucoma. (Source: the Mail online | Health)
Source: the Mail online | Health - January 1, 2022 Category: Consumer Health News Source Type: news

How to sleep: The tea shown to improve sleep quality in two weeks
THE HERBAL tea chamomile has been identified as improving sleep quality, however it has no effect on insomnia. (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2021 Category: Consumer Health News Source Type: news

Does Your Period Interrupt Your Sleep? Here ’s How To Put Your Insomnia To Bed.
Your flow can disrupt your day, but it can feel especially frustrating when your period keeps you awake at night. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 28, 2021 Category: Pharmaceuticals Authors: Laken Brooks, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Effect of grief on ageing populations' physical and mental well-being
In this study,4 Aoyama and colleagues considered excessive alcohol consumption in bereaved individuals and explored the association with complex grief and major depressive disorder (MDD). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 21, 2021 Category: Consumer Health News Source Type: news

Lay awake with a racing mind: the associations between sexual objectification, insomnia, and affective symptoms - Jiang Y, Wong NHL, Chan YC, Poon KT.
BACKGROUND: Sexual objectification is a form of interpersonal maltreatment that women may experience in daily life. Research has focused on testing how it leads to various psychological distresses. However, little research has examined its influences on wo... (Source: SafetyLit)
Source: SafetyLit - December 20, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

The relevance of insomnia in the diagnosis of perinatal depression: validation of the Italian version of the Insomnia Symptom Questionnaire - De Chiara L, Mazza C, Ricci E, Koukopoulos AE, Kotzalidis GD, Bonito M, Callovini T, Roma P, Angeletti G.
BACKGROUND: Sleep disorders are common in perinatal women and may underlie or trigger anxiety and depression. We aimed to translate and validate and evaluate the psychometric properties of the Italian version of the Insomnia Symptom Questionnaire (ISQ), in... (Source: SafetyLit)
Source: SafetyLit - December 14, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma
The objective responsive rate observed in this study suggests a potential benefit for many patients with triple-class exposed disease with an off-the-shelf therapy.”As of September 2021, 165 patients were treated with teclistamab at the SC 1.5 mg/kg dose across both Phase 1 and Phase 2 of MajesTEC-1.1 The primary objectives of the MajesTEC-1 Phase 1 study (NCT03145181) were to identify the recommended SC RP2D (part 1) and characterize the safety and tolerability of teclistamab at the RP2D (part 2). The primary objective of the MajesTEC-1 Phase 2 study (NCT04557098) was to evaluate the efficacy of teclistamab at the R...
Source: Johnson and Johnson - December 13, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma
ATLANTA, Ga., December 11, 2021– The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the MonumenTAL-1 Phase 1 first-in-human dose-escalation study of talquetamab (NCT03399799). Talquetamab is the only investigational off-the-shelf T cell redirecting bispecific antibody in clinical development targeting both GPRC5D, a novel multiple myeloma target, and CD3 on T cells.[1] Results from the study show that no new safety signals were observed with longer follow-up.1 Heavily pretreated patients with multiple myeloma treated with talquetamab at the recommended subcutaneous (SC)...
Source: Johnson and Johnson - December 11, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Insomnia in Healthcare Workers Worsened During the Pandemic Insomnia in Healthcare Workers Worsened During the Pandemic
Sleep disturbances have increased among healthcare workers during the pandemic, leading to higher rates of psychological distress, according to the results of a new study.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 8, 2021 Category: Intensive Care Tags: Hospital Medicine News Source Type: news

The association of problematic use of social media and online videogames with aggression is mediated by insomnia severity: a cross-sectional study in a sample of 18- to 24-year-old individuals - Bersani FS, Barchielli B, Ferracuti S, Panno A, Carbone GA, Massullo C, Farina B, Corazza O, Prevete E, Tarsitani L, Pasquini M, Biondi M, Imperatori C.
One of the worrying concomitants of problematic use of  Internet (PUI) is aggression. Although the mechanisms underlying such link have not been completely clarified, it has been suggested that problematic use of social media and online videogames (i.e., t... (Source: SafetyLit)
Source: SafetyLit - December 8, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Childhood trauma and insomnia increase suicidal ideation in schizophrenia patients: a cross-sectional study - Zhang Y, Fang X, Tang B, Fan K, Wen N, Zhao K, Xu W, Tang W, Chen Y.
This study aimed to investigate the effect of childhood trauma, especially its specific dimensions, and clinical risk factors for suicidal ideation in patients with schizophrenia. METHODS: A total of 83 inpatients with schizophrenia wer... (Source: SafetyLit)
Source: SafetyLit - December 6, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Insomnia, a New Modifiable Risk Factor for Heart Failure? Insomnia, a New Modifiable Risk Factor for Heart Failure?
A new study investigates the association between chronic insomnia and incident heart failure. Might treatment of insomnia symptoms reduce cardiovascular risk and HF incidence?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

CBT for Insomnia in Geriatric Primary Care Patients CBT for Insomnia in Geriatric Primary Care Patients
Is cognitive behavioral therapy for insomnia effective in patients over 75 years of age, who often have more medical and psychosocial concerns than younger patients?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2021 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Does Long COVID Exist in the Pediatric Age Group?
Discussion With COVID-19, the scientific research process is playing out daily in the press where the general public can see for themselves and share in the new knowledge and frustrating events that occur usually behind the curtain of science. People try to understand the little snippets of new knowledge that come forth and how they fit into the COVID problem, and most importantly how it may affect themselves, the people they care about and their community. Patients and families daily ask questions of their health care providers who themselves have the same questions, and answer something like “We’re learning s...
Source: PediatricEducation.org - November 29, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Psychedelics can change humanity for the better. It ’s time to unlock their power | Rick Doblin
Studies of MDMA, ketamine, psilocybin mushrooms and other psychedelics have shown tremendous potential for therapeutic applicationsI study psychedelics. The organization I work for – theMultidisciplinary Association for Psychedelic Studies (MAPS) – has been researching MDMA since 1992, seven years after the substance was prohibited. Our organization was founded in 1985.One of a few treatments designated a breakthrough therapy by the FDA, MDMA-assisted therapy for post-traumatic stress disorder is an incredibly promising treatment for this devastating mental injury. Survivors of PTSD may struggle to stay connect...
Source: Guardian Unlimited Science - November 26, 2021 Category: Science Authors: Rick Doblin Tags: Fungi Biology Science Medicine Source Type: news

CBT Prevents Depression in Up to 50% of Patients With Insomnia CBT Prevents Depression in Up to 50% of Patients With Insomnia
Cognitive Behavioral Therapy for insomnia (CBT-I) can help reduce the likelihood of depression development by more than 50% in older patients with insomnia, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 24, 2021 Category: Neurology Tags: Psychiatry News Source Type: news

Sleep training for adults prevents depression
Breaking bad habits in order to prepare your mind and body for a good night's sleep, may help prevent depression in older adults with insomnia. (Source: PsycPORT.com)
Source: PsycPORT.com - November 24, 2021 Category: Psychiatry Source Type: news

Swell in Off-Label Antipsychotic Prescribing'Not Harmless'Swell in Off-Label Antipsychotic Prescribing'Not Harmless '
A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 23, 2021 Category: Cardiology Tags: Psychiatry News Source Type: news

Comment on 'The relationship between the severity of insomnia and falls in the elderly' - Tan SG, Soysal P.
[The publisher has not provided an abstract for this article.] Language: en... (Source: SafetyLit)
Source: SafetyLit - November 22, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Using patient questionnaires for improving clinical management and outcomes
In this interview with lead author Christopher Gibbons, we find out more about the recently published review,   Routine provision of information on patient-reported outcome measures to healthcare providers and patients in clinical practice.Tell us about this reviewThe aim of this Cochrane Review was to find out whether healthcare workers who receive information from questionnaires completed by their patients give better health care and whether their patients have better health. We collected and analysed all relevant studies.What did you find out?Patient questionnaire responses fed back to health workers and patients m...
Source: Cochrane News and Events - November 17, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Prevalence of insomnia symptoms and associated risk factors in UK Biobank participants with hazardous alcohol use and major depression - Kolla BP, Biernacka JM, Mansukhani MP, Colby C, Coombes BJ.
INTRODUCTION: We aimed to examine the prevalence of insomnia symptoms (IS), sleep duration, and associated risk factors in participants with hazardous/harmful alcohol use (HAU), major depressive disorders (MDD), and HAU+MDD. METHODS: Data from the ... (Source: SafetyLit)
Source: SafetyLit - November 16, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Insomnia Linked to Higher Risk for Aneurysm, SAH Insomnia Linked to Higher Risk for Aneurysm, SAH
Along with smoking and hypertension, insomnia is associated with a significantly increased risk for brain aneurysm as well as subarachnoid hemorrhage and could be a novel risk factor.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 11, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

The New First-Line Treatment for Adult Insomnia The New First-Line Treatment for Adult Insomnia
For those who can relate to these words sung by John Lennon:"Lyin'there and staring at the ceiling. Waiting for a sleepy feeling."Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 10, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news

Zolpidem: efficacy and side effects for insomnia - Edinoff AN, Wu N, Ghaffar YT, Prejean R, Gremillion R, Cogburn M, Chami AA, Kaye AM, Kaye AD.
PURPOSE OF REVIEW: Insomnia is a common type of sleep disorder defined by an ongoing difficulty initiating or maintaining sleep or nonrestorative sleep with subsequent daytime impairment. The sleep disturbances in insomnia usually manifest as difficulty in... (Source: SafetyLit)
Source: SafetyLit - November 10, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline du...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Insomnia Tied to Raised Risk of Aneurysm
Title: Insomnia Tied to Raised Risk of AneurysmCategory: Health NewsCreated: 11/3/2021 12:00:00 AMLast Editorial Review: 11/4/2021 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - November 4, 2021 Category: Sleep Medicine Source Type: news

Shirley Ballas health: Strictly star's shocking confession - 'I don't sleep'
IN AMONGST Shirley Ballas' health troubles, which most recently has seen her undergo a biopsy to test a lump under her arm, the Strictly judge has also confessed to another worrying disorder that impacts her life - insomnia. (Source: Daily Express - Health)
Source: Daily Express - Health - November 3, 2021 Category: Consumer Health News Source Type: news

Dramatic COVID-Related Jump in Z-Drug Prescriptions Dramatic COVID-Related Jump in Z-Drug Prescriptions
The COVID-19 lockdown has been linked to an increase in prescriptions of drugs to treat depression, anxiety, and insomnia — especially for women.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 28, 2021 Category: Infectious Diseases Tags: Psychiatry News Source Type: news

Patterns of pain complaints and insomnia symptoms are associated with abusive supervision in the Norwegian working population: a latent class analysis - Sannes AC, Christensen JO, Matre D, Nielsen MB, Gjerstad J.
OBJECTIVES: Previous findings suggest that abusive supervision, i.e.,  subordinates' perceptions of their supervisor's behaviours as hostile (excluding physical aggression), may increase the risk of health complaints. In addition, recent data suggest that ... (Source: SafetyLit)
Source: SafetyLit - October 27, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

How to sleep: The 30-second rhythmic exercise that induces sleep within ‘four minutes’
SLEEP deprivation has become a global epidemic, with up to 30 percent of people in developed countries suffering from chronic insomnia. While many resort to medication to fix their sleep woes, certain DIY techniques have also proven successful aids in the past. One method put forward by a professor, could induce sleep in less time than it takes to eat a bowl of cereal. (Source: Daily Express - Health)
Source: Daily Express - Health - October 22, 2021 Category: Consumer Health News Source Type: news

The prevalence of depressive and insomnia symptoms, and their association with quality of life among older adults in rural areas in China - Yang JJ, Cai H, Xia L, Nie W, Zhang Y, Wang S, Shi Y, Ng CH, Liu H, Xiang YT.
This study examined the prevalence of depressive and insomnia symptoms, and their associa... (Source: SafetyLit)
Source: SafetyLit - October 21, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Headband could beat insomnia by zapping the brain while sufferers wear it for 20 minutes at bedtime 
A headband worn for 20 minutes before bedtime may help beat insomnia. One person in ten in the UK has difficulty getting to sleep or staying asleep, with women twice as likely to be affected as men. (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2021 Category: Consumer Health News Source Type: news